Maria Re to Middle Aged
This is a "connection" page, showing publications Maria Re has written about Middle Aged.
Connection Strength
0.059
-
Impact of Different Antiretroviral Strategies on Total HIV-DNA Level in Virologically Suppressed HIV-1 Infected Patients. Curr HIV Res. 2017; 15(6):448-455.
Score: 0.011
-
Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection. Int J Infect Dis. 2013 Oct; 17(10):e875-82.
Score: 0.009
-
The lower respiratory tract microbiome of critically ill patients with COVID-19. Sci Rep. 2021 05 12; 11(1):10103.
Score: 0.004
-
COVID-19 Outcomes in Patients With Uncontrolled HIV-1 Infection. J Acquir Immune Defic Syndr. 2021 01 01; 86(1):e15-e17.
Score: 0.004
-
Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: a case-control study. New Microbiol. 2019 Jul; 42(3):145-149.
Score: 0.003
-
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B. J Viral Hepat. 2019 05; 26(5):568-575.
Score: 0.003
-
Rosuvastatin and atorvastatin preserve renal function in HIV-1-infected patients with chronic kidney disease and hyperlipidaemia. HIV Clin Trials. 2018 06; 19(3):120-128.
Score: 0.003
-
Simplification to dual-therapy containing lamivudine and darunavir/ritonavir or atazanavir/ritonavir in HIV-infected patients on virologically suppressive antiretroviral therapy. Infect Dis (Lond). 2018 05; 50(5):352-360.
Score: 0.003
-
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial. PLoS One. 2017; 12(11):e0187393.
Score: 0.003
-
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods. PLoS One. 2017; 12(11):e0187755.
Score: 0.003
-
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns. BMC Infect Dis. 2017 08 22; 17(1):581.
Score: 0.003
-
Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study). Infect Dis (Lond). 2017 Oct; 49(10):737-747.
Score: 0.003
-
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia. APMIS. 2017 Jun; 125(6):511-522.
Score: 0.003
-
Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients. AIDS. 2017 03 13; 31(5):681-688.
Score: 0.003
-
High prevalence of serum antibody against human T cell leukemia virus type I (HTLV-I) among the Bismam Asmat population (Indonesian New Guinea). AIDS Res Hum Retroviruses. 1989 Oct; 5(5):551-4.
Score: 0.002